Elucidating the precise pharmacological mechanism of action (MOA) of naturally developing compounds can be demanding. Even though Tarselli et al. (60) formulated the initial de novo synthetic pathway to conolidine and showcased that this naturally occurring compound properly suppresses responses to each chemically induced and inflammation-derived p